retatrutide mechanism clinical trials Retatrutide: Understanding the of action Retatrutide Dosing Guide: 1-12 mg

This delay increases stomach fullness signals and contributes to early post-meal satiety, making individuals eat less at subsequent meals

Exenatide produced mixed results

These benefits and changes in eating habits can be life-changing for many people, but may not last if the medication is stopped

As it turns out, any form of physical activity is useful

Freezing forms ice crystals that physically damage the peptide and can crack the cartridge

Developer: Eli Lilly and Company | Administration in Trials: Once-weekly subcutaneous injection First successful Phase 3 trial (TRIUMPH-4, topline Dec 2025): Up to 28.7% average body weight loss at 68 weeks (highest dose) in adults with obesity/overweight and knee osteoarthritis